Answers are grounded in this paper and cite their sources.
Microbiology and ImmunologyVolume 40, Issue 10 p. 701-709 ReviewFree Access Rotavirus Vaccines: A Perspective† Osamu Nakagomi, Corresponding Author Osamu Nakagomi Department of Microbiology, Akita University School of Medicine, Akita, Akita, 010 JapanAddress correspondence to Dr. Osamu Nakagomi, Department of Microbiology, Akita University School of Medicine, 1-1 Hondo, Akita, Akita 010, Japan.Search for more papers by this authorToyoko Nakagomi, Toyoko Nakagomi Department of Microbiology, Akita University School of Medicine, Akita, Akita, 010 JapanSearch for more papers by this author Osamu Nakagomi, Corresponding Author Osamu Nakagomi Department of Microbiology, Akita University School of Medicine, Akita, Akita, 010 JapanAddress correspondence to Dr. Osamu Nakagomi, Department of Microbiology, Akita University School of Medicine, 1-1 Hondo, Akita, Akita 010, Japan.Search for more papers by this authorToyoko Nakagomi, Toyoko Nakagomi Department of Microbiology, Akita University School of Medicine, Akita, Akita, 010 JapanSearch for more papers by this author First published: October 1996 https://doi.org/10.1111/j.1348-0421.1996.tb01130.xCitations: 4 †This paper is dedicated to late Professor Shiro Uesugi who had continuously encouraged us for his last 13 years of life. AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Abbreviations CDC National Centers for Disease Control and Prevention of the United States of America ER endoplasmic reticulum ETEC enterotoxigenic Escherichia coli PFU plaque-forming unit IEL intraepithelial lymphocyte NSP nonstructural protein RER rough endoplasmic reticulum RRV simian rotavirus SC secretory component TCID50 50% tissue culture infectious dose VP viral protein REFERENCES 1Ball, J.M., Tian, P., Zeng, C.Q.-Y., Morris, A.P., and Estes, M.K. 1996. Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein. Science 272: 101– 104. CrossrefCASPubMedWeb of Science®Google Scholar 2Bern, C., and Glass, R.I. 1994. Impact of diarrheal diseases worldwide, p. 1– 26. In A.Z. Kapikian (ed), Viral infections of the gastrointestinal tract, 2nd ed., Marcel Dekker, Inc., New York, Basel, Hong Kong. Web of Science®Google Scholar 3Bernstein, D.I., Glass, R.I., Rodgers, G., Davidson, B.L., and Sack, D.A. 1995. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. J. Am. Med. Assoc. 273: 1191– 1196. CASPubMedWeb of Science®Google Scholar 4Bernstein, D.I., Sander, D.S., Smith, V.E., Schiff, G.M., and Ward, R.L. 1991. Protection from rotavirus reinfection: 2-year prospective study. J. Infect. Dis. 164: 277– 283. CrossrefCASPubMedWeb of Science®Google Scholar 5Bernstein, D.I., Smith, V.E., Sander, D.S., Pax, K.A., and Schiff, G.M. 1990. Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J. Infect. Dis. 162: 1055– 1062. CrossrefCASPubMedWeb of Science®Google Scholar 6Bishop, R.F. 1994. Natural history of human rotavirus infections, p. 131– 167. In A.Z. Kapikian (ed), Viral infections of the gastrointestinal tract, 2nd ed., Marcel Dekker, Inc., New York, Basel, Hong Kong. Web of Science®Google Scholar 7Bishop, R.F., Barnes, G.L., Cipriani, E., and Lund, J.S. 1983. Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children. N. Engl. J. Med. 309: 72– 76. CrossrefCASPubMedWeb of Science®Google Scholar 8Bishop, R.F., Davidson, G.P., Holmes, I.H., and Ruck, B.J. 1973. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet ii: 1218– 1283. Google Scholar 9Burns, J., Sidat-Pajouh, M., Krishnaney, A.A., and Greenberg, H.B. 1996. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 272: 104– 107. CrossrefCASPubMedWeb of Science®Google Scholar 10Burns, J.W., Krishnaney, A.A., Vo, P.T., Rouse, R.V., Anderson, L.J., and Greenberg, H.B. 1995. Analyses of homologous rotavirus infection in the mouse model. Virology 207: 143– 153. CrossrefCASPubMedWeb of Science®Google Scholar 11Chan, W.K., Au, K.S., and Estes, M.K. 1988. Topography of simian rotavirus nonstructural glycoprotein (NS28) in the endoplasmic reticulum membrane. Virology 164: 435– 442. CrossrefCASPubMedWeb of Science®Google Scholar 12Chiba, S., Nakata, S., Ukae, S., and Adachi, N. 1993. Virological and serological aspects of immune resistance to rotavirus gastroenteritis. Clin. Infect. Dis. 16: s117– s121. CrossrefPubMedWeb of Science®Google Scholar 13Chiba, S., Yokoyama, T., Nakata, S., Morita, Y., Urasawa, T., Taniguchi, K., Urasawa, S., and Nakao, T. 1986. Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet ii: 417– 421. CrossrefCASGoogle Scholar 14Christy, C., Offit, P., Clark, H.F., and Treanor, J. 1993. Evaluation of a bovine-human rotavirus reassortant vaccine in infants. J. Infect. Dis. 168: 1598– 1599. CrossrefCASPubMedWeb of Science®Google Scholar 15Clark, H.F. 1995. Bovine rotavirus (strain WC3) reassortant vaccine in infants. Presented at the Fifth Rotavirus Vaccine Workshop, Atlanta, Georgia. Google Scholar 16Conner, M.E., Crawford, S.E., Barone, C., and Estes, M.K. 1993. Rotavirus vaccine administered parenterally induces protective immunity. J. Virol. 67: 6633– 6641. PubMedWeb of Science®Google Scholar 17Conner, M.E., Matson, D.A., and Estes, M.K. 1994. Rotavirus vaccines and vaccination. In R.F. Ramig (ed), Rotaviruses, Springer-Verlag, Berlin, Heiderberg, New York. CrossrefGoogle Scholar 18DeMol, P., Zissis, G., Butzler, J.-P., Mutwewingabo, A., and Andre, F.E. 1986. Failure of live, attenuated oral rotavirus vaccine. Lancet ii: 108. CrossrefGoogle Scholar 19Erickson, B.L., Graham, D.Y., Mason, B.B., Hanssen, H.H., and Estes, M.K. 1983. Two types of glycoprotein precursors are produced by the simian rotavirus SA11. Virology 127: 320– 332. CrossrefPubMedWeb of Science®Google Scholar 20Estes, M.K. 1996. Rotaviruses and their replication, p. 1625– 1655. In B.N. Fields, D.M. Knipe, and P.M. Howley (eds), Virology, Lippincott-Raven Publishers, Philadelphia. Google Scholar 21Glass, R.I., Gentsch, J., and Ivanoff, B. 1996. New lessons for rotavirus vaccines. Science 272: 46– 48. CrossrefCASPubMedWeb of Science®Google Scholar 22Glass, R.I., Gentsch, J., and Smith, J.C. 1994. Rotavirus vaccines: success by reassortment? Science 265: 1389– 1391. Google Scholar 23Greenberg, H.B., Vo, P.T., and Jones, R. 1986. Cultivation and characterization of three strains of murine rotavirus. J. Virol. 57: 585– 590. CASPubMedWeb of Science®Google Scholar 24Ho, M.S., Glass, R.I., Pinsky, P.F., and Anderson, L.J. 1988. Rotavirus as a cause of diarrheal morbidity and mortality in the United States. J. Infect. Dis. 158: 1112– 1116. CrossrefCASPubMedWeb of Science®Google Scholar 25Ho, M.S., Glass, R.I., Pinsky, P.F., Young-Okoh, N., Sapen-field, W.M., Buehler, J.W., Gunter, N., and Anderson, L.J. 1988. Diarrheal death in American children. J. Am. Med. Assoc. 260: 3281– 3285. CrossrefPubMedWeb of Science®Google Scholar 26Hoshino, Y., and Kapikian, A.Z. 1994. Rotavirus antigens, p. 179– 227. In R.F. Ramig (ed), Rotaviruses, Springer Verlag, Berlin, Heiderberg, New York. CrossrefGoogle Scholar 27Hoshino, Y., Sereno, M.M., Midthun, K., Flores, J., Kapikian, A.Z., and Chanock, R.M. 1985. Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity. Proc. Natl. Acad. Sci. U.S.A. 82: 8701– 8704. CrossrefCASPubMedWeb of Science®Google Scholar 28Kabcennel, A.K., Poruchynsky, M.S., Bellamy, A.R., Greenberg, H.B., and Atkinson, P.H. 1988. Two forms of VP7 are involved in assembly of SA11 rotavirus in endoplasmic reticulum. J. Virol. 62: 2929– 2941. PubMedWeb of Science®Google Scholar 29Kaga, E., and Nakagomi, O. 1994. The distribution of G (VP7) and VP4 (P) serotypes among human rotaviruses recovered from Japanese children with diarrhea. Microbiol. Immunol. 38: 317– 320. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 30Kapikian, A.Z. 1994. Jennerian and modified Jennerian approach to vaccination against rotavirus diarrhea in infants and young children: an introduction, p. 409– 417. In A.Z. Kapikian (ed), Viral infections of the gastrointestinal tract, 2nd ed., Marcel Dekker, Inc., New York, Basel, Hong Kong. Google Scholar 31Kapikian, A.Z. 1994. Rhesus rotavirus-based human rotavirus vaccines and observations on selected non-Jennerian approaches to rotavirus vaccination, p. 443– 470. In A.Z. Kapikian (ed), Viral infections of the gastrointestinal tract, 2nd ed., Marcel Dekker, Inc., New York, Basel, Hong Kong. Google Scholar 32Kapikian, A.Z., and Chanock, R.M. 1996. Rotaviruses, p. 1657– 1708. In B.N. Fields, D.M. Knipe, and P.M. Howley (eds), Virology, Lippincott-Raven Publishers, Philadelphia. Google Scholar 33Kapikian, A.Z., Flores, J., Hoshino, Y., Glass, R.I., Midthun, K., Gorziglia, M., and Chanock, R.M. 1986. Rotavirus: the major etiologic agent of severe infantile diarrhea may be controllable by a “Jennerian” approach to vaccination. J. Infect. Dis. 153: 815– 822. CrossrefCASPubMedWeb of Science®Google Scholar 34Kapikian, A.Z., Midthun, K., Hoshino, Y., Flores, J., Wyatt, R.G., Glass, R.I., Askaa, J., Nakagomi, O., Nakagomi, T., Chanock, R.M., Levine, M.L., Clements, R., Dolin, R., Wright, P.F., Belshe, R.B., Anderson, E.L., and Potash, L. 1985. Rhesus rotavirus: a candidate vaccine for prevention of human rotavirus disease, p. 357– 367. In R.A. Lerner, R.M. Chanock, and F. Brown (eds), Vaccines 85, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York. Google Scholar 35Kilgore, P.E., Holman, R.C., Clarke, M.J., and Glass, R.I. 1995. Trends of diarrheal disease-associated mortality in US children, 1968 through 1991. J. Am. Med. Assoc. 274: 1143– 1148. PubMedWeb of Science®Google Scholar 36Mazanec, M.B., Kaetzel, C.S., Lamm, M.E., Fletcher, D., and Nedrud, J.G. 1992. Intracellular neutralization of virus immunoglobulin A antibodies. Proc. Natl. Acad. Sci. U.S.A. 89: 6901– 6905. CrossrefCASPubMedWeb of Science®Google Scholar 37McNeal, M.M., Broome, R.L., and Ward, R.L. 1994. Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination. Virology 204: 642– 650. CrossrefCASPubMedWeb of Science®Google Scholar 38Moon, H.W. 1994. Pathophysiology of viral diarrhea, p. 27– 52. In A.Z. Kapikian (ed), Viral infections of the gastrointestinal tract, 2nd ed., Marcel Dekker, Inc., New York, Basel, Hong Kong. Web of Science®Google Scholar 39Murphy, F.A., Fauquet, C.M., Bishop, D.H.L., Ghabrial, S.A., Jarvis, A.W., Martelli, G.P., Mayo, M.A., and Summers, M.D. 1995. Sixth Report of the International Committee on Taxonomy of Viruses, Springer-Verlag, Vienna. Google Scholar 40Nakagomi, O., and Nakagomi, T. 1996. Molecular epidemiology of human rotaviruses: genogrouping by RNA-RNA hybridization. Arch. Virol. (in press). Google Scholar 41Nakagomi, O., and Nakagomi, T. 1993. Interspecies transmission of rotaviruses studied from the perspective of genogroup. Microbiol. Immunol. 37: 337– 348. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 42Nakagomi, O., Nakagomi, T., Akatani, K., and Ikegami, N. 1989. Identification of rotavirus genogroups by RNA-RNA hybridization. Mol. Cell. Probes 3: 251– 261. CrossrefCASPubMedWeb of Science®Google Scholar 43Nakagomi, O., Ohshima, A., Aboudy, Y., Shif, I., Mochizuki, M., Nakagomi, T., and Gotlieb-Stematsky, T. 1990. Molecular identification by RNA-RNA hybridization of a human rotavirus that is closely related to feline and canine origin. J. Clin. Microbiol. 28: 1198– 1203. CASPubMedWeb of Science®Google Scholar 44Nakagomi, T., and Nakagomi, O. 1989. RNA-RNA hybridization identifies a human rotavirus that is genetically related to feline rotavirus. J. Virol. 63: 1431– 1434. CrossrefCASPubMedWeb of Science®Google Scholar 45Offit, P.A. 1994. Immunologic determinants of protection against rotavirus disease, p. 229– 254. In R.F. Ramig (ed), Rotaviruses, Springer Verlag, Berlin, Heidelberg, New York. CrossrefGoogle Scholar 46Offit, P.A. 1994. Rotaviruses: immunological determinants of protection against infection and disease. Adv. Virus Res. 44: 161– 202. CrossrefCASPubMedWeb of Science®Google Scholar 47Offit, P.A., and Blavat, G. 1986. Identification of two rotavirus genes determining neutralization specificities. J. Virol. 57: 376– 378. CASPubMedWeb of Science®Google Scholar 48Offit, P.A., and Clark, H.F. 1985. Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies. J. Virol. 54: 58– 64. PubMedWeb of Science®Google Scholar 49Offit, P.A., Clark, H.F., Kornstein, M.J., and Plotkin, S.A. 1984. A murine model for oral infection with a primate rotavirus (simian SA11). J. Virol. 51: 233– 236. CASPubMedWeb of Science®Google Scholar 50Offit, P.A., and Dudzik, K.I. 1989. Noninfectious rotavirus (Strain RRV) induces a response in mice which protects against rotavirus challenge. J. Clin. Microbiol. 27: 885– 888. PubMedWeb of Science®Google Scholar 51Petrie, B.L., Estes, M.K., and Graham, D.Y. 1983. Effects of tunicamycin on rotavirus morphogenesis and infectivity. J. Virol. 46: 270– 274. CASPubMedWeb of Science®Google Scholar 52Rennels, M.B., Glass, R.I., Dennehy, P.H., Bernstein, D.I., Pichichero, M.E., Zito, E.T., Mack, M.E., Davidson, B.L., and Kapikian, A.Z. 1996. Safety and efficacy of high-dose rhesus-human rotavirus vaccines—Report of the national multicenter trial. Pediatrics 97: 7– 13. CASPubMedWeb of Science®Google Scholar 53Shaw, R.D., Hempson, S.J., and Mackow, E.R. 1995. Rotavirus diarrhea is caused by nonreplicating viral particles. J. Virol. 69: 5946– 5950. CrossrefCASPubMedWeb of Science®Google Scholar 54Smith, J.C., Haddix, A.C., Teutsch, S.M., and Glass, R.I. 1995. Cost-effectiveness analysis of a rotavirus immunization program for the United States. Pediatrics 96: 609– 615. CASPubMedWeb of Science®Google Scholar 55Snodgrass, D.R., and Wells, P.W. 1976. Rotavirus infection in lambs: studies on passive protection. Arch. Virol. 52: 201– 205. CrossrefCASPubMedWeb of Science®Google Scholar 56Suzuki, H., Kitaoka, S., Sato, T., Konno, T., Iwasaki, Y., Numazaki, Y., and Ishida, N. 1986. Further investigation on the mode of entry of human rotavirus into cells. Arch. Virol. 91: 135– 144. CrossrefCASPubMedWeb of Science®Google Scholar 57Treanor, J.J., Clark, H.F., Pichichero, M., Christy, C., Gouvea, V., Shrager, D., Palazzo, S., and Offit, P. 1995. Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants. Pediatr. Infect. Dis. J. 14: 301– 307. CrossrefCASPubMedWeb of Science®Google Scholar 58Vesikari, T., Isolauri, E., D'Hondt, E., Delem, A., Andre, F.E., and Zissis, G. 1984. Protection of infants against rotavirus diarrhea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet i: 977– 981. CrossrefCASGoogle Scholar 59Vesikari, T., and Kapikian, A.Z. 1994. Rotavirus vaccine development, p. 213– 229. In E. Kurstak (ed), Modern vaccinology, Plenum Publishing Corporation, New York. CrossrefGoogle Scholar 60Vesikari, T., Ruuska, T., Bogaerts, H., Delem, A., and Andre, F.E. 1985. Dose-response study of RIT4237 oral rotavirus vaccine in breast-fed and formula-fed infants. Pediatr. Infect. Dis. J. 4: 622– 625. CrossrefCASWeb of Science®Google Scholar 61Wolf, J.L., Cuker, G., Blacklow, R., Dambrauskas, R., and Trier, J.S. 1981. Susceptibility of mice to rotavirus infection: effects of age and administration of corticosteroids. Infect. Immun. 33: 565– 574. CASPubMedWeb of Science®Google Scholar Citing Literature Volume40, Issue10October 1996Pages 701-709 ReferencesRelatedInformation
No takes yet. Share an insight, caveat, or question.
Nakagomi et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: